These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 39009937)

  • 21. Temperature dependence of the SARS-CoV-2 affinity to human ACE2 determines COVID-19 progression and clinical outcome.
    Zhou Z; Yang Z; Ou J; Zhang H; Zhang Q; Dong M; Zhang G
    Comput Struct Biotechnol J; 2021; 19():161-167. PubMed ID: 33343834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural analysis of a simplified model reproducing SARS-CoV-2 S RBD/ACE2 binding site.
    Buonocore M; Santoro A; Grimaldi M; Covelli V; Firoznezhad M; Rodriquez M; Santin M; D'Ursi AM
    Heliyon; 2022 Nov; 8(11):e11568. PubMed ID: 36406731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production.
    Fraternale A; De Angelis M; De Santis R; Amatore D; Masini S; Monittola F; Menotta M; Biancucci F; Bartoccini F; Retini M; Fiori V; Fioravanti R; Magurano F; Chiarantini L; Lista F; Piersanti G; Palamara AT; Nencioni L; Magnani M; Crinelli R
    FASEB J; 2023 Feb; 37(2):e22741. PubMed ID: 36583713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human ACE2 Genetic Polymorphism Affecting SARS-CoV and SARS-CoV-2 Entry into Cells.
    Hattori T; Saito T; Okuya K; Takahashi Y; Miyamoto H; Kajihara M; Igarashi M; Takada A
    Microbiol Spectr; 2022 Aug; 10(4):e0087022. PubMed ID: 35862965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular interactions between perlecan LG3 and the SARS-CoV-2 spike protein receptor binding domain.
    Gressett TE; Hossen ML; Talkington G; Volic M; Perez H; Tiwari PB; Chapagain P; Bix G
    Protein Sci; 2024 Jan; 33(1):e4843. PubMed ID: 37996967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Astemizole as a drug to inhibit the effect of SARS-COV-2 in vitro.
    Wang X; Lu J; Ge S; Hou Y; Hu T; Lv Y; Wang C; He H
    Microb Pathog; 2021 Jul; 156():104929. PubMed ID: 33932547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycyrrhizic Acid Inhibits SARS-CoV-2 Infection by Blocking Spike Protein-Mediated Cell Attachment.
    Li J; Xu D; Wang L; Zhang M; Zhang G; Li E; He S
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-Throughput Assay for Identifying Diverse Antagonists of the Binding Interaction between the ACE2 Receptor and the Dynamic Spike Proteins of SARS-CoV-2.
    Sammons RM; Bohanon AL; Kowtha A; Dejong A; Cho EJ; Kaoud TS; Dalby KN
    ACS Infect Dis; 2022 Nov; 8(11):2259-2270. PubMed ID: 36315931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repositioning of histamine H
    Ge S; Wang X; Hou Y; Lv Y; Wang C; He H
    Eur J Pharmacol; 2021 Apr; 896():173897. PubMed ID: 33497607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach.
    Lv Y; Wang S; Liang P; Wang Y; Zhang X; Jia Q; Fu J; Han S; He L
    Anal Bioanal Chem; 2021 May; 413(11):2995-3004. PubMed ID: 33608752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction.
    Cao W; Dong C; Kim S; Hou D; Tai W; Du L; Im W; Zhang XF
    Biophys J; 2021 Mar; 120(6):1011-1019. PubMed ID: 33607086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).
    Guo X; Chen Z; Xia Y; Lin W; Li H
    J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms.
    Ali A; Vijayan R
    Sci Rep; 2020 Aug; 10(1):14214. PubMed ID: 32848162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Biosensor Assay Based on Coiled-Coil-Mediated Human ACE2 Receptor Capture for the Analysis of Its Interactions with the SARS-CoV-2 Receptor Binding Domain.
    Forest-Nault C; Koyuturk I; Gaudreault J; Pelletier A; L'Abbé D; Cass B; Bisson L; Burlacu A; Delafosse L; Stuible M; Henry O; De Crescenzo G; Durocher Y
    Methods Mol Biol; 2024; 2762():89-105. PubMed ID: 38315361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
    Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
    Elife; 2021 Aug; 10():. PubMed ID: 34435953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
    Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
    Front Immunol; 2021; 12():691715. PubMed ID: 34149735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human variation in the protein receptor ACE2 affects its binding affinity to SARS-CoV-2 in a variant-dependent manner.
    Santos TM; Lisboa ABP; Rodrigues W; Gomes H; Abrahão J; Del-Bem LE
    J Biomol Struct Dyn; 2023 Apr; 41(7):2947-2955. PubMed ID: 35196964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oroxylin A is a severe acute respiratory syndrome coronavirus 2-spiked pseudotyped virus blocker obtained from Radix Scutellariae using angiotensin-converting enzyme II/cell membrane chromatography.
    Gao J; Ding Y; Wang Y; Liang P; Zhang L; Liu R
    Phytother Res; 2021 Jun; 35(6):3194-3204. PubMed ID: 33587321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomechanical Characterization of SARS-CoV-2 Spike RBD and Human ACE2 Protein-Protein Interaction.
    Cao W; Dong C; Kim S; Hou D; Tai W; Du L; Im W; Zhang XF
    bioRxiv; 2020 Jul; ():. PubMed ID: 32766576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corilagin and 1,3,6-Tri-
    Binette V; Côté S; Haddad M; Nguyen PT; Bélanger S; Bourgault S; Ramassamy C; Gaudreault R; Mousseau N
    Phys Chem Chem Phys; 2021 Jul; 23(27):14873-14888. PubMed ID: 34223589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.